A phase II study of gemcitabine (gemzar, LY188011) in the treatment of recurrent or persistent endometrial carcinoma: A gynecologic oncology group study

✍ Scribed by David L. Tait; John A. Blessing; James S. Hoffman; Kathleen N. Moore; Nick M. Spirtos; Jason A. Lachance; Jacob Rotmensch; David S. Miller

• Book ID: 113962702
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 151 KB
• Volume: 121
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2010.11.027